Novolog Insulin Pen Pharmokinetics

FDA OKs First Rapid-Acting Insulin Biosimilar for Diabetes

The FDA approved insulin-aspart-szjj (Merilog) as the first rapid-acting insulin biosimilar product to treat adults and children with diabetes, the agency announced Friday. Like i

Hosted on MSN · 16h

Sanofi gets FDA approval for NovoLog insulin biosimilar

Sanofi (NASDAQ:SNY) has received FDA approval for Merilog, a biosimilar of Novo Nordisk's (NVO) rapid-acting insulin product NovoLog, for the improvement of glycemic control in adults and children with diabetes mellitus.

Business Insider · 16h

FDA approves Sanofi biosimilar product for treatment of diabetes

The U.S. Food and Drug Administration approved Merilog as biosimilar to Novolog for the improvement of glycemic control in adults and pediatric

MarketWatch · 18h

FDA Approves First Rapid-Acting Insulin Biosimilar Product for Treatment of Diabetes

Agency Continues Efforts to Increase Access to Insulin Treatment Options SILVER SPRING, Md., /PRNewswire/ -- Today, the U.S. Food and Drug Administration approved Merilog (insulin-aspart-szjj) as biosimilar to Novolog (insulin aspart) for the improvement of glycemic control in adults and pediatric patients with diabetes mellitus.

pharmaphorum3d

Civica plans shake-up of insulin sector with low-cost biosimilars

The biosimilars – which will be interchangeable with Sanofi's Lantus (insulin glargine), Novo Nordisk's Novolog (insulin aspart ... than $55 for a box of five pen cartridges – which Civica ...

Hosted on MSN18d

Attorney General secures $35 Novo Nordisk insulin for Minnesotans

Ellison says the settlement requires Novo Nordisk to provide insulin products—including Novolog, Tresiba ... prescription (3 vials or 2 packs of pens) for customers paying with cash.

Results that may be inaccessible to you are currently showing.

Hide inaccessible results

Trending now